Publication Name	World Journal of Hepatology
Manuscript ID	89628
Country	China

Received	2023-11-07 13:38
Peer-Review Started	2023-11-07 13:39
First Decision by Editorial Office Director	2023-12-06 04:48
Return for Revision	2023-12-07 12:08
Revised	2023-12-27 06:06
Publication Fee Transferred
Second Decision by Editor	2024-02-01 02:41
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-02-01 07:10
Articles in Press	2024-02-01 07:10
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-13 03:03
Publish the Manuscript Online	2024-03-27 13:28

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Retrospective Study
Article Title	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy
Manuscript Source	Unsolicited Manuscript
All Author List	Pei-Xin Zhang, Xiao-Wei Zheng, Ya-Fei Zhang, Jun Ye, Wei Li, Qian-Qian Tang, Jie Zhu, Gui-Zhou Zou and Zhen-Hua Zhang
ORCID	Author(s) ORCID Number Ya-Fei Zhang http://orcid.org/0000-0003-4594-186X Gui-Zhou Zou http://orcid.org/0000-0002-4690-5580 Zhen-Hua Zhang http://orcid.org/0000-0002-8480-9004
Funding Agency and Grant Number	Funding Agency Grant Number Anhui Provincial Natural Science Foundation 2108085MH298 Scientific Research Project of the Second Affiliated Hospital of Anhui Medical University 2019GMFY02, 2021lcxk027 Scientific Research Project of Colleges and Universities in Anhui Province KJ2021A0323
Corresponding Author	Zhen-Hua Zhang, MD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei 230601, Anhui Province, China. zzh1974cn@163.com
Key Words	Chronic hepatitis B; Hepatitis B e antigen-positive; Peginterferon-alfa; Prediction model; Response-guided therapy strategy
Core Tip	This study identified the optimal independent predictors of treatment response in previously treated patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B who received peginterferon alpha therapy. Using single-factor and multi-factor logistic regression analyses, scoring prediction models and response-guided therapy strategies were established. These tools offer guidance for physicians to adjust treatment plans for patients who have not achieved HBeAg seroconversion after long-term nucleos(t)ide analog therapy, carrying significant practical implications for alleviating social and medical burdens.
Publish Date	2024-03-27 13:28
Citation	Zhang PX, Zheng XW, Zhang YF, Ye J, Li W, Tang QQ, Zhu J, Zou GZ, Zhang ZH. Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy. World J Hepatol 2024; 16 (3): 405-417
URL	https://www.wjgnet.com/1948-5182/full/v16/i3/405.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i3.405

Full Article (PDF)	WJH-16-405-with-cover.pdf
Manuscript File	89628_Auto_Edited-YJP.docx
Answering Reviewers	89628-Answering reviewers.pdf
Audio Core Tip	89628-Audio core tip.m4a
Biostatistics Review Certificate	89628-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	89628-Conflict-of-interest statement.pdf
Copyright License Agreement	89628-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	89628-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	89628-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	89628-Language certificate.pdf
Supplementary Material	89628-Supplementary material.pdf
Peer-review Report	89628-Peer-review(s).pdf
Scientific Misconduct Check	89628-Bing-Wang JJ-2.png
Scientific Editor Work List	89628-Scientific editor work list.pdf
CrossCheck Report	89628-CrossCheck report.pdf